Table 2.

Data for Hindlimb Suspension Animal Model Development: Table with Serum Data for Pure Control and HS (No Microdamage Induction)

		Control (WB)			Hindlimb suspension (HS)
	Day	0	21	35	0	21	35
	n	5	5	5	10	9	8
Osteocalcin, ng/mL	Avg.	2.47	1.72	2.07	1.93	1.39	1.32*
	SD	1.93	0.78	0.52	0.83	0.85	0.48
TRAP5b, U/L	Avg.	0.77	0.94	0.88	0.85	1.16**	1.16**
	SD	0.19	0.20	0.11	0.17	0.43	0.30

Serum TRACP5b (RatTRAP, SBA Sciences) and OCN (Rat Osteocalcin, BT-490, Biomedical Technologies) were measured by ELISA [absorbance measured at 450 nm (OCN) and 405 nm (TRACP5b)] in order to determine relative systemic expression of markers of bone resorption and formation, respectively.

^*p = .07 versus HS day 0.

^**p = .07 WB versus HS for that day.